Glassman Wealth Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-296
Closed -$50.9K 1469
2023
Q4
$50.9K Buy
296
+24
+9% +$3.69K 0.01% 447
2023
Q3
$40.2K Buy
272
+57
+27% +$10.3K 0.01% 473
2023
Q2
$47K Buy
215
+1
+0.5% +$223 0.01% 423
2023
Q1
$46.9K Buy
214
+43
+25% +$9.33K 0.01% 423
2022
Q4
$35.6K Buy
171
+8
+5% +$1.76K 0.01% 500
2022
Q3
$36K Buy
163
+9
+6% +$2.05K 0.01% 462
2022
Q2
$32K Sell
154
-2
-1% -$426 0.01% 492
2022
Q1
$38K Buy
156
+15
+11% +$3.63K 0.01% 473
2021
Q4
$37K Buy
141
+4
+3% +$1.04K 0.01% 444
2021
Q3
$36K Buy
137
+13
+10% +$3.56K 0.01% 430
2021
Q2
$31K Buy
124
+15
+14% +$3.15K 0.01% 446
2021
Q1
$21K Buy
109
+1
+0.9% +$201 ﹤0.01% 517
2020
Q4
$23K Buy
108
+23
+27% +$4.59K 0.01% 492
2020
Q3
$15K Buy
85
+21
+33% +$3.88K ﹤0.01% 518
2020
Q2
$12K Buy
64
+39
+156% +$6.38K ﹤0.01% 465
2020
Q1
$4K Buy
25
+16
+178% +$2.55K ﹤0.01% 562
2019
Q4
$1K Buy
9
+6
+200% +$865 ﹤0.01% 1016
2019
Q3
$0 Hold
3
﹤0.01% 1325
2019
Q2
$0 Buy
+3
New +$332 ﹤0.01% 1321

Other funds holding RMD

Glassman Wealth Services's RMD Position: Q1 2024 in Review

Glassman Wealth Services sold out of ResMed (RMD) in Q1 2024, closing a stake of 296 shares — an estimated $50.9K sold.

Glassman Wealth Services first reported a position in RMD in Q2 2019 and held it in 19 quarters. The position peaked at $50.9K in Q4 2023. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Glassman Wealth Services reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 296 ResMed shares in Q1 2024, an estimated $50.9K.
  • Glassman Wealth Services first reported a position in ResMed in Q2 2019 and held it in 19 quarters.
  • Glassman Wealth Services's ResMed position peaked at $50.9K in Q4 2023.
  • 718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.